Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.
作者信息
Yu Jiangquan, Zheng Ruiqiang, Qiu Haibo
机构信息
Department of Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu Province, China.
Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province, China.
出版信息
J Transl Int Med. 2021 Jul 9;9(2):68-70. doi: 10.2478/jtim-2021-0029. eCollection 2021 Jun.
Abstract
摘要
相似文献
1
Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.用于2019冠状病毒病的恢复期血浆：剂量是关键。
J Transl Int Med. 2021 Jul 9;9(2):68-70. doi: 10.2478/jtim-2021-0029. eCollection 2021 Jun.
2
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.纽约2019冠状病毒病住院患者中，严重急性呼吸综合征冠状病毒2康复期血浆与标准血浆的对比：一项双盲随机试验
Crit Care Med. 2021 Jul 1;49(7):1015-1025. doi: 10.1097/CCM.0000000000005066.
3
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.4例重症2019冠状病毒病患儿的恢复期血浆治疗：病例系列
Crit Care Explor. 2020 Oct 1;2(10):e0237. doi: 10.1097/CCE.0000000000000237. eCollection 2020 Oct.
4
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series.康復期血漿治療對印尼 8 例非插管 COVID-19 患者的療效：病例系列研究。
J Med Case Rep. 2021 Nov 23;15(1):564. doi: 10.1186/s13256-021-03059-y.
5
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.用恢复期血浆治疗 COVID-19：从过去的冠状病毒爆发中吸取的教训。
Clin Microbiol Infect. 2020 Oct;26(10):1436-1446. doi: 10.1016/j.cmi.2020.08.005. Epub 2020 Aug 11.
6
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
7
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.康复期或对照血浆输注治疗早期门诊 COVID-19 后，地方性人冠状病毒抗体水平保持不变。
mBio. 2023 Feb 28;14(1):e0328722. doi: 10.1128/mbio.03287-22. Epub 2023 Jan 10.
8
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.恢复期个体对 SARS-CoV-2 刺突蛋白的体液反应下降。
mBio. 2020 Oct 16;11(5):e02590-20. doi: 10.1128/mBio.02590-20.
9
Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.新冠病毒肺炎确诊儿童恢复期血浆输注的分析：一项系统评价
Florence Nightingale J Nurs. 2022 Oct;30(3):301-309. doi: 10.5152/FNJN.2022.21260.
10
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.恢复期血浆或高免疫球蛋白用于 COVID-19 患者：一项实时系统评价。
Cochrane Database Syst Rev. 2021 May 20;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub4.
引用本文的文献
1
Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients.恢复期血浆疗法对中重度 COVID-19 患者死亡率的影响。
Transfus Apher Sci. 2022 Dec;61(6):103455. doi: 10.1016/j.transci.2022.103455. Epub 2022 May 11.
本文引用的文献
1
Convalescent plasma to treat COVID-19: clinical experience and efficacy.恢复期血浆治疗 COVID-19：临床经验和疗效。
Aging (Albany NY). 2021 Mar 18;13(6):7758-7766. doi: 10.18632/aging.202795.
2
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes.高滴度恢复期抗 SARS-CoV-2 血浆的管理：从供者选择到监测受者结局。
Hum Immunol. 2021 Apr;82(4):255-263. doi: 10.1016/j.humimm.2021.02.007. Epub 2021 Feb 16.
3
COVID-19 convalescent plasma: Interim recommendations from the AABB.新型冠状病毒肺炎康复者血浆：美国血库协会临时建议
Transfusion. 2021 Apr;61(4):1313-1323. doi: 10.1111/trf.16328. Epub 2021 Mar 7.
4
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
5
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.恢复期血浆治疗重症 COVID-19：一项倾向评分匹配对照研究。
Nat Med. 2020 Nov;26(11):1708-1713. doi: 10.1038/s41591-020-1088-9. Epub 2020 Sep 15.
6
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.使用恢复期血浆治疗 2019 年冠状病毒病患者显示出死亡率显著降低的信号。
Am J Pathol. 2020 Nov;190(11):2290-2303. doi: 10.1016/j.ajpath.2020.08.001. Epub 2020 Aug 11.
7
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.恢复期血浆疗法对重症和危及生命的 COVID-19 患者临床改善时间的影响：一项随机临床试验。
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
8
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma.治疗新型冠状病毒肺炎（COVID-19）患者的恢复期血浆。
Am J Pathol. 2020 Aug;190(8):1680-1690. doi: 10.1016/j.ajpath.2020.05.014. Epub 2020 May 27.
9
Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol.从新冠肺炎康复供者中提取的血浆用于治疗 COVID-19 危重症患者的研究（COVID-19 血浆研究）：一项多中心研究方案。
Intern Emerg Med. 2020 Aug;15(5):819-824. doi: 10.1007/s11739-020-02384-2. Epub 2020 May 28.
10
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者：快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
Zotero 插件